Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000002

Chief Financial Officer sold 2,932 shares at $27.09 ($79,428)

  • Chief Financial Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jones Cecilia Chief Financial Officer 2025-12-30 Option exercise 10b5-1 +6,000 40,326 D: show line 1 in the form
Jones Cecilia Chief Financial Officer 2025-12-30 Sale 10b5-1 −2,932 $27.09 $79,428 37,394 D: show line 2 in the form
Open-market sales · 2,932 sh · avg $27.09 · $79,428

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jones Cecilia Chief Financial Officer 2025-12-30 Option exercise · Performance share units 10b5-1 −6,000 0 D: show line 3 in the form
Loading xslF345X05/wk-form4_1767402864.xml…